Curran Terrie

DirectorMyovant Sciences Ltd. (MYOV) · full profile →Form 4 · filed Mar 10, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
8
1 non-derivative · 7 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 10, 2023Disposed to issuer(D)4K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 10, 2023Disposed to issuer(D)11K0
Mar 10, 2023Disposed to issuer(D)23K0
Mar 10, 2023Disposed to issuer(D)23K0
Mar 10, 2023Disposed to issuer(D)5K0
Mar 10, 2023Disposed to issuer(D)22K0
Mar 10, 2023Disposed to issuer(D)21K0
Mar 10, 2023Disposed to issuer(D)34K0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-017716) within minutes of acceptance. Every field above traces to the original document. Verify it directly: